Lindbrook Capital’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $13.1K | Sell |
527
-4
| -0.8% | -$99 | ﹤0.01% | 1540 |
|
|
2024
Q4 | $10K | Buy |
531
+413
| +350% | +$7.78K | ﹤0.01% | 1648 |
|
|
2024
Q3 | $1.78K | Sell |
118
-56
| -32% | -$843 | ﹤0.01% | 2385 |
|
|
2024
Q2 | $4.98K | Buy |
174
+30
| +21% | +$858 | ﹤0.01% | 1994 |
|
|
2024
Q1 | $4.21K | Hold |
144
| – | – | ﹤0.01% | 1968 |
|
|
2023
Q4 | $4.86K | Buy |
144
+124
| +620% | +$4.18K | ﹤0.01% | 1906 |
|
|
2023
Q3 | $614 | Buy |
+20
| New | +$614 | ﹤0.01% | 2494 |
|
|
2023
Q2 | – | Sell |
-76
| Closed | -$3.1K | – | 2836 |
|
|
2023
Q1 | $3.1K | Buy |
+76
| New | +$3.1K | ﹤0.01% | 2059 |
|
|
2022
Q4 | – | Sell |
-15
| Closed | -$1K | – | 2985 |
|
|
2022
Q3 | $1K | Buy |
15
+7
| +88% | +$467 | ﹤0.01% | 2445 |
|
|
2022
Q2 | $0 | Buy |
+8
| New | – | ﹤0.01% | 2714 |
|